Administrative regional variation in cardiovascular risk among patients with gout: implications for the management of cardiovascular complications.
作者信息
Choi Sang Tae
机构信息
Division of Rheumatology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
出版信息
J Rheum Dis. 2023 Oct 1;30(4):209-210. doi: 10.4078/jrd.2023.0047. Epub 2023 Sep 6.
Abstract
摘要
相似文献
1
Administrative regional variation in cardiovascular risk among patients with gout: implications for the management of cardiovascular complications.痛风患者心血管风险的行政区域差异：对心血管并发症管理的启示
J Rheum Dis. 2023 Oct 1;30(4):209-210. doi: 10.4078/jrd.2023.0047. Epub 2023 Sep 6.
2
Regional variations of cardiovascular risk in gout patients: a nationwide cohort study in Korea.痛风患者心血管风险的区域差异：韩国一项全国性队列研究
J Rheum Dis. 2023 Jul 1;30(3):185-197. doi: 10.4078/jrd.2023.0011. Epub 2023 Jun 8.
3
Association between gout and cardiovascular outcomes in adults with no history of cardiovascular disease: large data linkage study in New Zealand.无心血管疾病病史的成年人中痛风与心血管结局的关联：新西兰大型数据关联研究
BMJ Med. 2022 Jun 22;1(1):e000081. doi: 10.1136/bmjmed-2021-000081. eCollection 2022.
4
Pharmacologic Management of Gout in Patients with Cardiovascular Disease and Heart Failure.心血管疾病和心力衰竭患者痛风的药物治疗
Am J Cardiovasc Drugs. 2020 Oct;20(5):431-445. doi: 10.1007/s40256-020-00400-6.
5
[Hyperuricemia, gout and high cardiovascular risk - how to manage them in clinical practice].[高尿酸血症、痛风与高心血管风险——临床实践中如何应对]
Ter Arkh. 2019 Dec 15;91(12):75-83. doi: 10.26442/00403660.2019.12.000173.
6
Gout and rheumatoid arthritis, both to keep in mind in cardiovascular risk management: A primary care retrospective cohort study.痛风和类风湿性关节炎在心血管风险管理中均需牢记：一项初级保健回顾性队列研究。
Joint Bone Spine. 2017 Jan;84(1):59-64. doi: 10.1016/j.jbspin.2015.12.003. Epub 2016 May 25.
7
Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout.炎症性关节炎中的心血管风险：类风湿关节炎和痛风
Lancet Rheumatol. 2021 Jan;3(1):e58-e70. doi: 10.1016/S2665-9913(20)30221-6. Epub 2020 Sep 1.
8
Nurse-led cardiovascular disease risk management intervention for patients with gout.护士主导的痛风患者心血管疾病风险管理干预。
Eur J Cardiovasc Nurs. 2011 Jun;10(2):94-100. doi: 10.1016/j.ejcnurse.2010.05.001. Epub 2010 Jun 3.
9
Association between serum uric acid levels of patients with gout and their complications and examination fees: A cross-sectional analysis.痛风患者血尿酸水平与其并发症及检查费用的相关性：一项横断面分析。
Int J Rheum Dis. 2023 Apr;26(4):673-681. doi: 10.1111/1756-185X.14609. Epub 2023 Feb 15.
10
Risk Factors of Cardiovascular Pathology in Patients with Gout.
Curr Rheumatol Rev. 2023;19(1):72-75. doi: 10.2174/1573397118666220802141420.
引用本文的文献
1
Elevated Soluble Suppressor of Tumorigenicity 2 Levels in Gout Patients and Its Association with Cardiovascular Disease Risk Indicators.痛风患者中可溶性肿瘤抑制因子2水平升高及其与心血管疾病风险指标的关联。
Yonsei Med J. 2025 Mar;66(3):151-159. doi: 10.3349/ymj.2024.0001.
本文引用的文献
1
Regional variations of cardiovascular risk in gout patients: a nationwide cohort study in Korea.痛风患者心血管风险的区域差异：韩国一项全国性队列研究
J Rheum Dis. 2023 Jul 1;30(3):185-197. doi: 10.4078/jrd.2023.0011. Epub 2023 Jun 8.
2
Global burden of gout in 1990-2019: A systematic analysis of the Global Burden of Disease study 2019.1990 - 2019年全球痛风负担：对《2019年全球疾病负担研究》的系统分析
Eur J Clin Invest. 2023 Apr;53(4):e13937. doi: 10.1111/eci.13937. Epub 2023 Jan 7.
3
Cardiovascular Risks in Korean Patients with Gout: Analysis Using a National Health Insurance Service Database.韩国痛风患者的心血管风险：基于国民健康保险服务数据库的分析
J Clin Med. 2022 Apr 11;11(8):2124. doi: 10.3390/jcm11082124.
4
The growing rural-urban divide in US life expectancy: contribution of cardiovascular disease and other major causes of death.美国预期寿命城乡差距不断扩大：心血管疾病和其他主要死因的贡献。
Int J Epidemiol. 2022 Jan 6;50(6):1970-1978. doi: 10.1093/ije/dyab158. Epub 2021 Aug 12.
5
Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout.炎症性关节炎中的心血管风险：类风湿关节炎和痛风
Lancet Rheumatol. 2021 Jan;3(1):e58-e70. doi: 10.1016/S2665-9913(20)30221-6. Epub 2020 Sep 1.
6
A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes.心血管疾病、相关风险因素及当前治疗方案简述
Curr Pharm Des. 2019;25(38):4063-4084. doi: 10.2174/1381612825666190925163827.
7
Gout and cardiovascular disease: crystallized confusion.痛风与心血管疾病：结晶化的困惑。
Curr Opin Rheumatol. 2019 Mar;31(2):118-124. doi: 10.1097/BOR.0000000000000585.
8
Crystal-proven Gout and Characteristic Gout Severity Factors Are Associated with Cardiovascular Disease.晶体证实的痛风和特征性痛风严重程度因素与心血管疾病相关。
J Rheumatol. 2018 Jun;45(6):858-863. doi: 10.3899/jrheum.170555. Epub 2018 Apr 15.
9
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.别嘌醇或非布司他治疗痛风患者的心血管安全性。
N Engl J Med. 2018 Mar 29;378(13):1200-1210. doi: 10.1056/NEJMoa1710895. Epub 2018 Mar 12.
10
Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015.韩国痛风的患病率和发病率：来自 2007-2015 年国家健康索赔数据库的数据。
Rheumatol Int. 2017 Sep;37(9):1499-1506. doi: 10.1007/s00296-017-3768-4. Epub 2017 Jul 4.
Zotero 插件